Literature DB >> 7642220

Protein kinase C isoform expression in CD45RA+ and CD45RO+ T lymphocytes.

E Corrigan1, D Kelleher, C Feighery, A Long.   

Abstract

Differences in levels of specific enzymes utilized in intracellular signalling could be a factor in the distinct signalling properties observed in memory and naive T cells. We have studied the expression of both classical and non-classical protein kinase of C (PKC) isoenzymes in CD45RA and CD45RO cells using a combination of Western blot and flow cytometric analysis. These data indicate that CD45RA cells express higher levels of PKC alpha, PKC beta and PKC delta than CD45RO cells. In addition, CD45RA+ cells show greater proliferative activity when stimulated with phorbol myristate acetate (PMA) and calcium ionophore than their CD45RO+ counterparts. Variations in the levels of these isoenzymes could be implicated in functional differences, such as proliferation and cytokine production, in these cell subsets.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642220      PMCID: PMC1383895     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Isozymes of protein kinase C in human neutrophils and their modification by two endogenous proteinases.

Authors:  S Pontremoli; E Melloni; B Sparatore; M Michetti; F Salamino; B L Horecker
Journal:  J Biol Chem       Date:  1990-01-15       Impact factor: 5.157

2.  Phorbol diesters increase the phosphorylation of the leukocyte common antigen CD45 in human T cells.

Authors:  M Autero; C G Gahmberg
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

3.  Cellular events during memory T-cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis.

Authors:  A N Akbar; A Timms; G Janossy
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

4.  The structure, expression, and properties of additional members of the protein kinase C family.

Authors:  Y Ono; T Fujii; K Ogita; U Kikkawa; K Igarashi; Y Nishizuka
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

5.  Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase.

Authors:  N K Tonks; H Charbonneau; C D Diltz; E H Fischer; K A Walsh
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

6.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

7.  Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation.

Authors:  M Merkenschlager; L Terry; R Edwards; P C Beverley
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

8.  Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.

Authors:  M Streuli; L R Hall; Y Saga; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

9.  Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells.

Authors:  K L Leach; E A Powers; V A Ruff; S Jaken; S Kaufmann
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

10.  Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation.

Authors:  J T Pingel; M L Thomas
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

View more
  2 in total

1.  High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells.

Authors:  K Masur; K Lang; B Niggemann; K S Zanker; F Entschladen
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

2.  Linkage of protein kinase C-beta activation and intracellular interleukin-2 accumulation in human naive CD4 T cells.

Authors:  J Hassan; E Rainsford; D J Reen
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.